Cargando…

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma

Stomach adenocarcinoma (STAD) is the third leading cause of cancer-related deaths and the fifth most prevalent malignancy worldwide. Mitochondrial respiratory chain complexes play a crucial role in STAD pathogenesis. However, how mitochondrial respiratory chain complex genes (MRCCGs) affect the prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Jin, Feifan, Li, Huanjuan, Shen, Yuhuan, Shi, Weilin, Wang, Lina, Zhong, Lei, Wu, Gongqiang, Wu, Qiaoliang, Li, Yanchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105960/ https://www.ncbi.nlm.nih.gov/pubmed/37062830 http://dx.doi.org/10.1186/s12935-023-02913-x

Ejemplares similares

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma
por: Shi, Yu, et al.
Publicado: (2018)

Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
por: Wang, Xiaohui, et al.
Publicado: (2023)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma
por: Chang, Jingjia, et al.
Publicado: (2023)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
por: Li, Zhouhua, et al.
Publicado: (2022)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
por: Luo, Lianghua, et al.
Publicado: (2022)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma
por: Huang, Zhihao, et al.
Publicado: (2021)

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
por: Ma, Jianli, et al.
Publicado: (2023)

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis
por: Zhou, Kai, et al.
Publicado: (2020)

A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
por: Nguyen, Thinh T., et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
por: Lu, Lina, et al.
Publicado: (2023)

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
por: Yu, Wei, et al.
Publicado: (2022)

Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma
por: Zhao, Yan, et al.
Publicado: (2022)

A novel microRNA signature predicts survival in stomach adenocarcinoma
por: Ding, Bowen, et al.
Publicado: (2017)

Development a m(6)A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response
por: Shi, Guodong, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma
por: Zhang, Shuqiong, et al.
Publicado: (2022)

High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma
por: Jiang, Kaiyuan, et al.
Publicado: (2020)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis
por: Hong, Chunhong, et al.
Publicado: (2021)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma
por: Liu, Zining, et al.
Publicado: (2022)

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sge9afs94b0ae7vfbq3ngdncgl